Cerbios-Pharma gains new director of commercial business development

Will help firm to grow and strengthen HPAPI services

Stefano Console has joined Cerbios-Pharma as director of commercial business development.

Prior to joining Cerbios, Console was business and financial director at Micro-Macinazione.

Cerbios-Pharma is a Swiss firm based in Lugano specialising in the development and manufacturing of chemical and biological APIs.

APIs made by Cerbios cover small molecules (Chemical Division), large molecules and probiotics (Biological Division).

The Chemical Division specialises not only in reduced folates, but also in the manufacturing of High Potency Active Ingredients (HPAIs) with long-term experience in Vitamin D derivatives requiring sophisticated production units with high containment levels.

The Biological Division specializes in the research, development and production of Probiotics as active pharmaceutical ingredients, pharmaceutical finished products and feed additives.

You may also like